Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tokiko Nii"'
Autor:
Misato Nishimura, Tokiko Nii, Gulzhan Trimova, Shuhei Miura, Kazuo Umezawa, Akira Ushiyama, Tetsuo Kubota
Publikováno v:
Journal of Nephropathology, Vol 2, Iss 2, Pp 114-121 (2013)
Background: β2-glycoprotein I (β2GPI)-dependent antiphospholipid antibodies (aPLs) are considered to play a pivotal pathogenic role in antiphospholipid syndrome (APS) by inducing the expression of tissue factor, inflammatory cytokines, and chemokin
Externí odkaz:
https://doaj.org/article/e1c9e8d3cffe4a1ba8980d9f3f24b8ca
Autor:
Tokiko Nii, Tetsuo Kubota, Toshihiro Nanki, Yukiko Komano, Masayoshi Harigai, Hitoshi Kohsaka, Wataru Hirose, Kenji Nagasaka, Tetsushi Sakurai, Nobuyuki Miyasaka
Publikováno v:
Modern Rheumatology. 19:216-218
Autor:
Tetsuo Kubota, Toshihiro Nanki, Hitoshi Kohsaka, Tetsushi Sakurai, Tokiko Nii, Nobuyuki Miyasaka, Kenji Nagasaka, Masayoshi Harigai, Yukiko Komano, Wataru Hirose
Publikováno v:
Modern Rheumatology. 19:216-218
(2009). Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers. Modern Rheumatology: Vol. 19, No. 2, pp. 216-218.
Autor:
Kenji Nagasaka, Yukiko Komano, Tetsushi Sakurai, Masayoshi Harigai, Tetsuo Kubota, Nobuyuki Miyasaka, Wataru Hirose, Tokiko Nii, Yoshinori Nonomura, Hitoshi Kohsaka, Toshihiro Nanki, Takahiko Sugihara
Publikováno v:
Modern Rheumatology. 17:531-533
The recent widespread employing of potent biologic agents targeting tumor necrosis factor (TNF) for the therapy of rheumatoid arthritis (RA) raises the question as to whether patients treated in this way respond normally to the infl uenza vaccine. To